🇺🇸 FDA

Drug profile · INN

metformin hydrochloride

QTRILMET

approved A10BD
US status
approved
Patents linked
2
News articles
0

Quick answer

metformin hydrochloride (QTRILMET) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN metformin hydrochloride
Brand QTRILMET
Route ORAL
Formulation FOR SUSPENSION, EXTENDED RELEASE
ATC code A10BD
Originator Takeda Pharmaceuticals International AG

Related patents

Search patents →

  1. US 10668021

    Metformin hydrochloride osmotic pump tablet and preparation method therefor

    Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8900638

    Solid preparation comprising alogliptin and metformin hydrochloride

    Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is metformin hydrochloride?

metformin hydrochloride (QTRILMET) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for metformin hydrochloride?

QTRILMET is a marketed brand name for metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of metformin hydrochloride?

metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.